Steroid formulation

  • US 4,448,774 A
  • Filed: 12/22/1982
  • Issued: 05/15/1984
  • Est. Priority Date: 12/22/1982
  • Status: Expired due to Term
First Claim
Patent Images

1. An aqueous pharmaceutical solution suitable for oral administration comprising as an active ingredient a steroid selected from the group consisting of prednisolone, prednisolone sodium phosphate, prednisone and methyl prednisolone, the steroid being present at a concentration of at least 0.3 mg/ml, the pH of the formulation being between 5 and 8 and the formulation containing a pharmaceutically acceptable preservative, a pharmaceutically acceptable chelating agent, and being substantially free of ethanol.

View all claims

    Thank you for your feedback